During the past decade, Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"" #1 collaborator was "Aarhus University Hospital" with 1 trials as a collaborator, "Alexion" with 1 trials as a collaborator, "Alnylam Pharmaceuticals" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Clinica Universidad de Navarra, Universidad de Navarra" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"" are "Membranous Nephropathy" (3 trials), "Chronic Kidney Diseases" (2 trials), "Atypical Hemolytic Uremic Syndrome" (1 trials), "Autosomal Dominant Polycystic Kidney" (1 trials) and "C3 Glomerulonephritis" (1 trials). Many other conditions were trialed in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"" in a lesser frequency.

Most popular intervention types in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"" are "Drug" (6 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (1 trials), "Dapagliflozin 10Mg Tab" (1 trials), "In vitro assays." (1 trials), "Lisinopril" (1 trials) and "MOR202" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò"". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".